US 8785429
Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK
granted A61KA61K31/4375A61K31/4545
Quick answer
US patent 8785429 (Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK) held by Takeda Pharmaceutical Company Limited expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4375, A61K31/4545, A61K31/496, A61K31/506